Neda Shakour | Medicinal chemistry | Best Researcher Award

Posted on by ScienceFather

Dr. Neda Shakour | Medicinal chemistry | Best Researcher Award

Dr. Neda Shakour, Mashhad University of Medical Science, Iran

Dr. Neda Shakour is a distinguished medicinal chemist at Mashhad University of Medical Sciences, specializing in drug design for diabetes treatment. With a Ph.D. in Medicinal Chemistry, her research focuses on thiazolidinediones and in silico drug discovery. She has extensive teaching experience and has contributed to regulatory work at the Food and Drug Administration of Mashhad. Recognized with numerous awards and research grants, Dr. Shakour has published extensively on cancer therapies, metabolic diseases, and nanomedicine, making significant advancements in medical science. 🏆🔬

Publication Profile

Google Scholar

🎓 Education

Dr. Neda Shakour earned her Ph.D. in Medicinal Chemistry from Mashhad University of Medical Sciences, focusing on designing and synthesizing novel thiazolidinediones for diabetes treatment. She completed her M.Sc. in Organic Chemistry at the University of Zanjan, where she specialized in nanoscale compound synthesis. Her academic journey began with a B.Sc. in Chemistry from Islamic Azad University of Shahreza. Throughout her studies, Dr. Shakour demonstrated exceptional research capabilities, gaining recognition for her contributions to medicinal chemistry. 📘🧪

👩‍🏫 Experience

Dr. Neda Shakour has over a decade of teaching experience at institutions like the Non-Profit Institute of the Role of the World in Isfahan, Shahreza University, and Borujen University. From 2021 to 2023, she worked as a postdoctoral researcher at Mashhad University of Medical Sciences, specializing in drug discovery. Currently, she is actively contributing to the Food and Drug Administration of Mashhad, where she applies her expertise in medicinal chemistry to enhance drug regulation and healthcare policies. 📚🔎

🏅 Awards and Honors

Dr. Neda Shakour was awarded the Level 3 Research and Innovation Credit by the National Elite Foundation in 2010. In 2024-2025, she secured prestigious research grants for two groundbreaking projects on non-peptide GLP-1R natural agonists and kidney failure treatments. Her consistent recognition for research excellence underscores her impact in drug discovery and diabetes management. With her dedication to innovation, Dr. Shakour remains a leader in medicinal chemistry research. 🥇🔬

🔍 Research Focus

Dr. Neda Shakour’s research spans the design, synthesis, and biological evaluation of organic compounds, particularly thiazolidinediones for diabetes treatment. She specializes in in silico drug discovery, biomimetic synthesis, and the development of targeted therapies for metabolic diseases. Her work also addresses cancer treatments and fibrosis management, demonstrating a commitment to improving patient outcomes. Dr. Shakour’s research significantly advances therapeutic innovation in pharmaceutical science. 💡🧪

Publication Top Notes

  • 📖 The natural phenolic compounds as modulators of NADPH oxidases in hypertension – Phytomedicine 55, 200-213 – Cited by: 176 – Year: 2019 🌿

  • 📖 Statins and C-reactive protein: in silico evidence on direct interaction – Archives of Medical Science 16 (6), 1432-1439 – Cited by: 60 – Year: 2020 💊

  • 📖 Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review – Pharmacological Properties of Plant-Derived Natural Products – Cited by: 35 – Year: 2021 🌱

  • 📖 Docetaxel encapsulation in nanoscale assembly micelles for targeted metastatic breast cancer therapy – International Journal of Pharmaceutics 605, 120822 – Cited by: 31 – Year: 2021 🧬

  • 📖 In silico evidence of direct interaction between statins and β‐amyloid – Journal of Cellular Biochemistry 120 (3), 4710-4715 – Cited by: 23 – Year: 2019 🧠

  • 📖 Cellulose-based nanofibril composite materials for bacterial infection control – Frontiers in Bioengineering and Biotechnology 9, 732461 – Cited by: 22 – Year: 2021 🦠

  • 📖 Design, synthesis and biological evaluation of novel thiazolidinediones as antidiabetic agents – Bioorganic Chemistry 115, 105162 – Cited by: 20 – Year: 2021 🍎

  • 📖 Data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2 – BMC Pulmonary Medicine 23 (1), 1-14 – Cited by: 19 – Year: 2023 🩸

  • 📖 Candesartan inhibits tumor growth and fibrosis in colorectal cancer – Excli Journal 20, 863 – Cited by: 17 – Year: 2021 🧑‍⚕️

  • 📖 Dual targeting of TGF-β and PD-L1 in colorectal carcinoma – Life Sciences 328, 121865 – Cited by: 13 – Year: 2023 🧫

 

 

Young Jun Kim | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Young Jun Kim | Pharmaceutical Science | Best Researcher Award

professor, Korea university, South Korea

📌 Prof. Dr. Young Jun Kim is a distinguished food scientist 🥼 specializing in functional food, biotechnology, and nutrition. He is a Professor at Korea University (2013–present) and serves as Dean of the Dept. of Food and Biotechnology. He earned his Ph.D. in Food Science from Cornell University (2001), focusing on conjugated linoleic acids (CLA) in dairy products. He has held key positions, including Business Director at Caregen Co., Ltd. and Executive Vice Chairman of the Dietary Supplement Review Board. His research spans cholinergic compounds, antioxidants, and bioflocculants. Recognized with multiple awards, he continues to shape food science and regulatory policies. 🏆

Publication Profile

Scopus

🎓 Academic Background

Prof. Dr. Young Jun Kim holds a Ph.D. in Food Science 🥼 from Cornell University (2001), where his research focused on the production of conjugated linoleic acids (CLA) by rumen bacteria 🦠 and their enhancement in dairy products 🥛. He earned his M.S. in Food Science and Technology from Korea University (1996), investigating bioflocculant production by Corynebacterium sp. K-199 🧪. His academic journey began with a B.S. in Food Biotechnology from Korea University (1994), where he developed expertise in biotechnological applications in food science 🍽️. His research has significantly contributed to nutrition and functional food innovations. 🚀

🔬 Research Experience

Prof. Dr. Young Jun Kim has an extensive research background in food science, biotechnology, and functional compounds 🧪. As a Visiting Professor at the University of Saskatchewan (2023–2024), he explored cholinergic compounds for health, muscle strength improvement 💪, and α-GPC functionality. His postdoctoral research at Cornell University (2002–2004) involved cellulosome construction and polyphenol recovery from apple peel 🍏. He also worked on Arg-CLA’s antioxidant and anticancer properties at Seoul National University (2002). Earlier, at Boyce Thompson Institute, he contributed to edible vaccine development 🏥. His graduate research at Cornell and Korea University focused on CLA-enriched dairy 🥛 and bioflocculants for wastewater treatment. 🌿

🏆 Honors and Awards

Prof. Dr. Young Jun Kim has received numerous prestigious awards for his contributions to food science and nutrition 🧪. He was honored with the Minister of Science and ICT Commendation (2023) for fulfilling national R&D missions and received the Best Paper Award at the Korean Society of Food and Nutrition Science Conference (2023) 📜. His contributions to public health and nutrition earned him recognition from the U.S. Secretary of Health and Human Services (2021) 🇺🇸. He has also been listed in Marquis Who’s Who in Medicine and Healthcare (2009–2010) and won multiple research and lecture awards from Cornell University, Korea University, and IFT 🎓.

🔬 Research Focus

Prof. Dr. Y.J. Kim specializes in food science, nutrition, and bioactive compounds 🥗🧪. His research explores functional foods, fermentation, antioxidants, and muscle atrophy prevention. Recent studies focus on Arriheuk wheat sprout extract for muscle health, α-Glycerylphosphorylcholine production in fermented foods, and anti-inflammatory effects of barley sprout fermentation 🌱. Additionally, he investigates sleep-enhancing compounds, food sensory optimization, and bioactive extracts from plants 🍏🌿. His expertise extends to flavor chemistry, browning prevention in fresh produce, and interleukin inhibition for health applications 🏥. His work significantly contributes to nutritional science and functional food development.

Publication Top Notes

  • Suppressive Effects of Arriheuk Wheat Sprout Extract on Muscle Atrophy in Dexamethasone-Induced C2C12 Myotubes and a Mouse Model
    Year: 2024 🧬
  • Production of α-Glycerylphosphorylcholine in Fermented Roots, Tubers, and Fruits
    Year: 2024 🍠
  • UP165, Standardized Corn Leaf Extract and its Active Component 6-Methoxybenzoxazolinone Induce Non-Rapid Eye Movement Sleep through Melatonergic and GABAergic Mechanisms
    Year: 2024 🌿
  • Characterization of Taste and Aroma Profile in Pomegranate (Punica Granatum L.) Seed Oil Using Electronic Sensors, GC-MS/Olfactometry
    Year: 2024 🍎
  • Validation of Optimization Methods for Sensory Characteristics Using Rate-All-That-Apply and Intensity Scales: A Case Study of Apple Juice
    Year: 2024 🍏
  • Antioxidant Activity of Extracts of Balloon Flower Root (Platycodon Grandiflorum), Japanese Apricot (Prunus Mume), and Grape (Vitis Vinifera) and Their Effects on Beef Jerky Quality
    Year: 2024 🍇
  • Prediction Model of Browning Inhibitor Concentration and its Optimal Composition for Mass Processing of Ready-to-Eat Fresh-Cut ‘Fuji’ Apple (Malus Domestica Borkh.) Strains
    Year: 2024 🍏
  • Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia Gladiata Pods
    Cited by: 0
    Year: 2024 🌿
  • The Inhalation Effect of Osmanthus Fragrans var. Aurantiacus on Physiological Parameters in Chronically Stressed Rats
    Cited by: 1
    Year: 2024 🌸
  • Anti-Inflammatory Effects of Barley Sprout Fermented by Lactic Acid Bacteria in RAW264.7 Macrophages and Caco-2 Cells
    Cited by: 3
    Year: 2024 🌾

Chang Wang | Pharmacokinetic | Best Researcher Award

Posted on by ScienceFather

Mr. Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China

Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. 💊📚

 

Publication Profile

Scopus

Educational Background 🎓

Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. 💊📚

 

 

Academic Positions 🏥

Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. 💉💊

 

 

Research Focus

Mr. Chang Wang’s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLC–MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. 💉🧬

 

 

Publication Top Notes

  • Development and validation of a UPLC–MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoring – Wu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) 📅
  • Modulation of drug-metabolizing enzymes and transporters under hypoxia environment – Min, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 📖
  • Effects of intestinal microflora on drug metabolism – Chen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 💊
  • Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxia – Ding, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 🧠
  • Plasma proteomic study of acute mountain sickness susceptible and resistant individuals – Lu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 ⛰️
  • Research progress of long chain non-coding RNA H19 in anoxic environment mechanism – Yue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 🧬
  • Interaction of amoxicillin and nifedipine mediated by intestinal flora – Zhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 💊
  • Research progress on clinical gene polymorphism of clopidogrel resistance – Sun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 🧬
  • Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m – Luo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 🌄
  • Advances of studies on effect of drug transporter under hypoxia – Zhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 💉

 

 

Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Posted on by ScienceFather

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background 🎓

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. 🎓📚🔬

 

Professional Experience 🧑‍🔬

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience 📚👨‍🏫

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions 🏆🎖️

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). 🏅📚

 

Research Focus

 

Dr. Victor Chigozie’s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. 🌱💊

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace – D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Al‐Ouqaili, … (Cited by: 405, Year: 2022) 🦠
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa – FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) 🌿
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca – V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) 🍌
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica – VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) 🥭
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti – GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) 🦟
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka – OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) 💊
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review – M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) 🏥
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria – VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) 💉
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) – LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) 🍵
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … – DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) 🍃

HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Posted on by ScienceFather

Dr. HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Dr. HECTOR ABELARDO OCAMPO, Instituto Politécnico Nacional, Mexico

Dr. Héctor Abelardo González Ocampo is a dedicated researcher and full-time professor at the Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, focusing on sustainable aquaculture technologies. His innovative work includes developing microencapsulated phenolic extracts as antioxidant and immunostimulant additives in aquaculture diets. He holds several patents related to biotechnological additives and environmental impact. Dr. González supervises master’s and doctoral students in natural resource management and biotechnology, contributing significantly to academic development. His recent graduates have explored topics related to environmental health risks associated with marine species. 🌱🐟📚

Publication Profile

Google Scholar

Academic Experience and Contributions

Dr. Ocampo has a substantial teaching portfolio. He imparts knowledge in environmental impact and ecotoxicology to graduate students, thereby shaping the next generation of researchers in environmental sciences. His commitment to education ensures that his research impacts future leaders in sustainable practices and policies.

 

Conclusion

Dr. Héctor Abelardo Ocampo’s multifaceted expertise in sustainable aquaculture technologies, public health risk assessment, and his strong academic and patent record positions him as an exemplary candidate for the Research for Best Researcher Award. His work not only advances scientific knowledge but also contributes to practical solutions in environmental sustainability and public health safety, aligning perfectly with the award’s objectives.

Publication Top Notes  

  • Las áreas naturales protegidas de México 🌳 | Cited by: 91 | Year: 2014
  • The prebiotic inulin increases the phenoloxidase activity and reduces the prevalence of WSSV in whiteleg shrimp (Litopenaeus vannamei) cultured under laboratory conditions 🍤 | Cited by: 77 | Year: 2012
  • Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei 🦠 | Cited by: 57 | Year: 2013
  • Microbial immunostimulants reduce mortality in whiteleg shrimp (Litopenaeus vannamei) challenged with Vibrio sinaloensis strains ⚠️ | Cited by: 54 | Year: 2011
  • Mangrove forest and artisanal fishery in the southern part of the Gulf of California, Mexico 🌊 | Cited by: 51 | Year: 2013
  • Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics 🦪 | Cited by: 44 | Year: 2009
  • Human health risk assessment of pesticide residues in snappers (Lutjanus) fish from the Navachiste Lagoon complex, Mexico ⚠️ | Cited by: 38 | Year: 2015
  • Protective effect of microbial immunostimulants and antiviral plants against WSSV in Litopenaeus vannamei cultured under laboratory conditions 🌱 | Cited by: 37 | Year: 2014
  • Dietary microorganism and plant effects on the survival and immune response of Litopenaeus vannamei challenged with the white spot syndrome virus 🍃 | Cited by: 35 | Year: 2011
  • Isolation and characterization of infectious Vibrio sinaloensis strains from the Pacific shrimp Litopenaeus vannamei (Decapoda: Penaeidae) 🔬 | Cited by: 34 | Year: 2012

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Maryam Tabarzad | Pharmaceutical Science | Best Researcher Award

Assist Prof Dr Maryam Tabarzad, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Iran

Based on Dr. Maryam Tabarzad’s profile, she appears to be a strong candidate for the Best Researcher Award due to several key factors:

Publication profile

google scholar

Educational Background

  • MSc in E-learning in Medical Education (2023): Focused on enhancing lab skills through augmented reality in pharmacy students.
  • PhD in Pharmaceutical Biotechnology (2014): Specialized in DNA aptamers against Coagulation Factor VIII.
  • Pharm.D. (2007): Conducted research on bis(4-nitroaryl-1,4-Dihydropyridine) with pharmacological evaluations.

Professional Experience

  • Assistant Professor: Protein Technology Research Center, Shahid Beheshti University of Medical Science (2014-present).
  • Vice-Chancellor of Research Affairs: Protein Technology Research Center (2018-present).
  • Editorial Roles: Managing Editor for Trends in Peptide and Protein Sciences, Associate Editor for Iranian Journal of Pharmaceutical Research, and Editorial member for Future Natural Products.

Notable Publications

  1. Fathi et al. (2024): Investigated antimicrobial peptides for wound healing, published in Burns (Q2, IF: 3.2).
  2. Fathi et al. (2024): Explored structural features of antimicrobial peptides in Bioorganic Chemistry (Q1, IF: 5.1).
  3. Yazdanicherati et al. (2024): Studied the effect of antimicrobial peptides on gold nanoparticles, published in Modares Journal of Biotechnology.

Teaching Experience

  • Extensive teaching roles in pharmaceutical and medical biotechnology across various institutions, including University of Science and Culture, Gilan University of Medical Sciences, and Shahid Beheshti University of Medical Sciences.

Thesis Supervision

  • Supervised multiple Ph.D. and MSc theses in areas such as biosensors, peptide-nanomolecule interactions, and cancer research.

Conclusion

Dr. Maryam Tabarzad’s impressive academic credentials, significant contributions to pharmaceutical biotechnology, influential editorial roles, and robust teaching and supervisory experience make her a highly suitable candidate for the Best Researcher Award. Her research, particularly in the design and development of antimicrobial peptides and aptamers, along with her leadership in research and education, underscores her excellence in the field.

Publication top notes

Therapeutic applications of nucleic acid aptamers in microbial infections

Aptamers as smart ligands for nano-carriers targeting

Anti-inflammatory activity of bioactive compounds from microalgae and cyanobacteria by focusing on the mechanisms of action

Simultaneous detection of bovine and porcine DNA in pharmaceutical gelatin capsules by duplex PCR assay for Halal authentication

Silymarin antiproliferative and apoptotic effects: insights into its clinical impact in various types of cancer

Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers

Anti-cancer drug delivery using carbohydrate-based polymers

Trends in the design and development of specific aptamers against peptides and proteins

Peptide dendrimers as valuable biomaterials in medical sciences

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Posted on by ScienceFather

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.

 

Publication Profile 

Scopus

Education and Academic Achievements 📚🏅

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience 💼

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top Notes 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24